Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Russell who wrote (552)	2/23/1998 8:07:00 PM
From: LTK007	Respond to of 1580

Yes,they do,Bruce(have great lawyers,i.e.) and they have stated that they are very confident they can win.But I read one reference that the court battle could last for years,and my question then is,will Merck be able to market their Cox-2 drug during the court fight. I sense that Merck is taking the strategy that just because Searle developed the 1st Cox-2 drug this does not allow them to disallow future Cox-2 drugs,or,that is,drugs that would then form a family of Cox-2 drugs.Whatever,this is an interesting case with a lot at stake. max90